US4129724A - 9-Deoxy-9-methylene-PGF-3,4-didehydropiperidylamides - Google Patents

9-Deoxy-9-methylene-PGF-3,4-didehydropiperidylamides Download PDF

Info

Publication number
US4129724A
US4129724A US05/894,268 US89426878A US4129724A US 4129724 A US4129724 A US 4129724A US 89426878 A US89426878 A US 89426878A US 4129724 A US4129724 A US 4129724A
Authority
US
United States
Prior art keywords
prostaglandin analog
analog according
deoxy
methylene
pgf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US05/894,268
Inventor
Gordon L. Bundy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of US4129724A publication Critical patent/US4129724A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups

Definitions

  • the present application is a continuation-in-part of Ser. No. 786,250, filed Apr. 11, 1977, now U.S. Pat. No. 4,098,805.
  • the present invention relates to novel 9-deoxy-9-methylene-PFG, 3,4-didehydropiperidylamides, the essential material constituting a disclosure of which is incorporated here by reference from U.S. Pat. No. 4,098,805.

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to novel 9-deoxy-9-methylene-PGF ,3,4-didehydropiperidylamides. These compounds are useful pharmacological agents, and are useful for the same purposes as the corresponding 9-deoxy-9-methylene-PFG-type acids.

Description

CROSS REFERENCE TO RELATED APPLICATIONS
This application is a continuation-in-part of Ser. No. 786,250, filed Apr. 11, 1977, now U.S. Pat. No. 4,098,805, issued July 4, 1978.
The present application is a continuation-in-part of Ser. No. 786,250, filed Apr. 11, 1977, now U.S. Pat. No. 4,098,805. The present invention relates to novel 9-deoxy-9-methylene-PFG, 3,4-didehydropiperidylamides, the essential material constituting a disclosure of which is incorporated here by reference from U.S. Pat. No. 4,098,805.

Claims (32)

I claim:
1. A prostaglandin analog of the formula ##STR1## wherein Y1 is trans--CH═CH--, --C.tbd.C--, or --CH2 CH2 --
wherein M1 is ##STR2## wherein R5 is hydrogen or methyl; WHEREIN L1 is ##STR3## or a mixture of ##STR4## wherein R3 and R4 are hydrogen, methyl, or fluoro, being the same or different, with the proviso that one of R3 and R4 is fluoro only when the other is hydrogen or fluoro;
Wherein Z2 is
(1) --(CH2)3 --(CH2)g --CH2 --,
(2) --(ch2)3 --(ch2)g --CF2 --,
(3) --ch2 --o--ch2 --(ch2)g --CH2 --,
(4) --c.tbd.c--ch2 --(ch2)g --CH2 --,
(5) --ch2 --c.tbd.c--(ch2)g --CH2 --,
(6) ##STR5## WHEREIN G IS ONE, 2 OR 3; WHEREIN R7 is
(1) --(CH2)m --CH3, ##STR6## WHEREIN M IS ONE TO 5, INCLUSIVE, H IS ZERO OR ONE, T is chloro, fluoro, trifluoromethyl, alkyl of one to 3 carbon atoms, inclusive, or alkoxy of one to 3 carbon atoms, inclusive, and s is zero, one, 2, to 3, the various T's being the same or different, with the proviso that not moe than two T's are other than alkyl, with the further proviso that R7 is ##STR7## wherein T and s are as defined above, only when R3 and R4 are hydrogen or methyl, being the same or different; and
wherein R21 and R22 are hydrogen, alkyl of one to 12 carbon atoms, inclusive; aralkyl of 7 to 12 carbon atoms, inclusive, phenyl, phenyl substituted with one, 2, or 3 chloro or alkyl of one to 3 carbon atoms, inclusive, or phenyl substituted with hydroxycarbonyl or alkoxycarbonyl of one to 4 carbon atoms, inclusive.
2. A prostaglandin analog according to claim 1, wherein Y1 is --C.tbd.C--.
3. 9-Deoxy-9-methylene-13,14-didehydro-PGF1, 3,4-didehydropiperidylamide, a prostaglandin analog according to claim 2.
4. A prostaglandin analog according to claim 1, wherein Y1 is --CH2 CH2 --.
5. 9-Deoxy-9-methylene-13,14-dihydro-PGF1, 3,4-didehydropiperidylamide, a prostaglandin analog according to claim 4.
6. A prostaglandin analog according to claim 1, wherein Y1 is trans-CH=CH--.
7. A prostaglandin analog according to claim 6, wherein Z2 is aromatic.
8. 9-Deoxy-9-methylene-3,7-inter-m-phenylene-3oxa-4,5,6-trinor-PGF1, 3,4-didehydropiperidylamide, a prostaglandin analog according to claim 7.
9. 9-Deoxy-9-methylene-3,7-inter-m-phenylene-4,5,6-trinor-PGF1, 3,4-didehydropiperidylamide, a prostaglandin analog according to claim 7.
10. A prostaglandin analog according to claim 6, wherein Z2 is aliphatic.
11. A prostaglandin analog according to claim 10, wherein M1 is ##STR8##
12. 15-epi-9-deoxy-9-methylene-PGF1, 3,4-didehydropiperidylamide, a prostaglandin analog according to claim 11.
13. A prostaglandin analog according to claim 10, wherein M1 is ##STR9##
14. A prostaglandin analog according to claim 13, wherein Z2 is cis--CH═CH--CH2 --(CH2)g --CH2 --.
15. A prostaglandin analog according to claim 14, wherein R7 is ##STR10##
16. 9-Deoxy-9-methylene-17-phenyl-18,19,20-trinor-PGF1, 3,4-didehydropiperidylamide, a prostaglandin analog according to claim 15.
17. A prostaglandin analog according to claim 14, wherein R7 is ##STR11##
18. 9-Deoxy-9-methylene-16-phenoxy-17,18,19,20-tetranor-PGF1, 3,4-didehydropiperidylamide, a prostaglandin analog according to claim 17.
19. A prostaglandin analog according to claim 14, wherein R7 is --(CH2)m --CH3.
20. A prostaglandin analog according to claim 19, wherein m is 3.
21. A prostaglandin analog according to claim 20, wherein g is 3.
22. 2a,2b-Dihomo-9-deoxy-9-methylene-15-methyl-PGF1, 3,4-didehydropiperidylamide, a prostaglandin analog according to claim 21.
23. A prostaglandin analog according to claim 20, wherein g is one.
24. A prostaglandin analog according to claim 23, wherein at least one of R3 and R4 is methyl.
25. 9-Deoxy-9-methylene-16,16-dimethyl-PGF1,3,4-didehydropiperidylamide, a prostaglandin analog according to claim 24.
26. A prostaglandin analog according to claim 23, wherein at least one of R3 and R4 is fluoro.
27. 9-Deoxy-9-methylene-16,16-difluoro-PGF1, 3,4-didehydropiperidylamide, a prostaglandin analog according to claim 26.
28. A prostaglandin analog according to claim 23, wherein R3 and R4 are both hydrogen.
29. A prostaglandin analog according to claim 28, wherein R5 is methyl.
30. 9-Deoxy-9-methylene-15-methyl-PGF1, 3,4-didehydropiperidylamide, a prostaglandin analog according to claim 29.
31. A prostaglandin analog according to claim 28, wherein R5 is hydrogen.
32. 9-Deoxy-9-methylene-PGF1, 3,4-didehydropiperidylamide, a prostaglandin analog according to claim 31.
US05/894,268 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PGF-3,4-didehydropiperidylamides Expired - Lifetime US4129724A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/786,250 US4098805A (en) 1977-04-11 1977-04-11 9-deoxy-9-methylene-pgf-type amides

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US05/786,250 Continuation-In-Part US4098805A (en) 1977-04-11 1977-04-11 9-deoxy-9-methylene-pgf-type amides

Publications (1)

Publication Number Publication Date
US4129724A true US4129724A (en) 1978-12-12

Family

ID=25138056

Family Applications (11)

Application Number Title Priority Date Filing Date
US05/786,250 Expired - Lifetime US4098805A (en) 1977-04-11 1977-04-11 9-deoxy-9-methylene-pgf-type amides
US05/894,273 Expired - Lifetime US4129727A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PGF1 -pyrrolidylamides
US05/894,216 Expired - Lifetime US4127569A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PGF1 -hexamethyliminoamides
US05/894,270 Expired - Lifetime US4129726A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PGF1 -piperizinylamides
US05/894,269 Expired - Lifetime US4129725A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PGF1 -pyrrolinylamides
US05/894,272 Expired - Lifetime US4130720A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PGF-p-substituted phenyl esters
US05/894,271 Expired - Lifetime US4130584A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PGF sulfonylamides
US05/894,215 Expired - Lifetime US4128712A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PGF1 -morpholinylamides
US05/894,214 Expired - Lifetime US4145534A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PFG1 -piperidylamides
US05/894,268 Expired - Lifetime US4129724A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PGF-3,4-didehydropiperidylamides
US05/899,663 Expired - Lifetime US4137403A (en) 1977-04-11 1978-04-24 9-Deoxy-9-methylene-PGF2 cycloamides

Family Applications Before (9)

Application Number Title Priority Date Filing Date
US05/786,250 Expired - Lifetime US4098805A (en) 1977-04-11 1977-04-11 9-deoxy-9-methylene-pgf-type amides
US05/894,273 Expired - Lifetime US4129727A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PGF1 -pyrrolidylamides
US05/894,216 Expired - Lifetime US4127569A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PGF1 -hexamethyliminoamides
US05/894,270 Expired - Lifetime US4129726A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PGF1 -piperizinylamides
US05/894,269 Expired - Lifetime US4129725A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PGF1 -pyrrolinylamides
US05/894,272 Expired - Lifetime US4130720A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PGF-p-substituted phenyl esters
US05/894,271 Expired - Lifetime US4130584A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PGF sulfonylamides
US05/894,215 Expired - Lifetime US4128712A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PGF1 -morpholinylamides
US05/894,214 Expired - Lifetime US4145534A (en) 1977-04-11 1978-04-07 9-Deoxy-9-methylene-PFG1 -piperidylamides

Family Applications After (1)

Application Number Title Priority Date Filing Date
US05/899,663 Expired - Lifetime US4137403A (en) 1977-04-11 1978-04-24 9-Deoxy-9-methylene-PGF2 cycloamides

Country Status (8)

Country Link
US (11) US4098805A (en)
JP (1) JPS53127438A (en)
BE (1) BE865882A (en)
CH (1) CH635072A5 (en)
DE (1) DE2814710A1 (en)
FR (1) FR2387217A2 (en)
GB (1) GB1568018A (en)
NL (1) NL7803434A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169895A (en) * 1976-09-28 1979-10-02 Pfizer Inc. Antisecretory 16,16-dimethyl-17-oxaprostaglandins
US4118584A (en) * 1977-04-11 1978-10-03 The Upjohn Company 9-Deoxy-9-methylene-16-phenyl-PGF compounds
US4276435A (en) * 1979-04-02 1981-06-30 The Upjohn Company 19,20-Didehydro-PG1, sulfonyl amides
US4264524A (en) * 1979-04-02 1981-04-28 The Upjohn Company 19,20-Didehydro-PG1 amides
US4278812A (en) * 1979-04-02 1981-07-14 The Upjohn Company 19,20-Didehydro-PG2 sulfonyl amides
US4283351A (en) * 1979-04-02 1981-08-11 The Upjohn Company 19,20-Didehydro-13,14-dihydro-PG2 amides
US4264522A (en) * 1979-04-02 1981-04-28 The Upjohn Company 19-Hydroxy-PG amides
US4276434A (en) * 1979-04-02 1981-06-30 The Upjohn Company 19,20-Didehydro-13,14-dihydro-PG1, sulfonyl amides
US4283350A (en) * 1979-04-02 1981-08-11 The Upjohn Company 19,20-Didehydro-PG2 amides
US4264523A (en) * 1979-04-02 1981-04-28 The Upjohn Company 19,20-Didehydro-13,14-dihydro-PG1 amides
US4278813A (en) * 1979-04-02 1981-07-14 The Upjohn Company 19,20-Didehydro-13,14-dihydro-PG2, sulfonyl amides
US4292444A (en) * 1980-02-08 1981-09-29 Pfizer Inc. Sulfonyl prostaglandin carboxamide derivatives
US4349690A (en) * 1981-04-23 1982-09-14 The Upjohn Company 9-Deoxy-9-methylene-6-keto-PGE-type compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954741A (en) * 1972-06-07 1976-05-04 Pfizer Inc. N-substituted prostaglandin carboxamides
US3981868A (en) * 1973-05-31 1976-09-21 American Cyanamid Company Derivatives of 9-oxo-13-trans-prostenoic acid amides
FR2239458A1 (en) * 1973-07-31 1975-02-28 Aries Robert Prostaglandin amides - with antilipolytic, gonadotrophic, luteolytic, hypotensive and other activities associated with prostaglandins
US3890372A (en) * 1974-01-08 1975-06-17 Upjohn Co Amino substituted phenyl and naphthyl esters of PGF{HD 2{301 {B - type compounds
US3927197A (en) * 1974-04-19 1975-12-16 Pfizer Tertiary alcohol stabilized E-series prostaglandins
US4060534A (en) * 1976-01-23 1977-11-29 The Upjohn Company 9-Deoxy-9-methylene-PGF compounds
US4118584A (en) * 1977-04-11 1978-10-03 The Upjohn Company 9-Deoxy-9-methylene-16-phenyl-PGF compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
derwent Abstract 16389U-B, NL 7211860-Q, 05-03-78. *
Derwent Abstract 75530X/40, US 3981868, 21-09-76. *

Also Published As

Publication number Publication date
US4128712A (en) 1978-12-05
JPS53127438A (en) 1978-11-07
US4098805A (en) 1978-07-04
US4130584A (en) 1978-12-19
FR2387217A2 (en) 1978-11-10
US4145534A (en) 1979-03-20
DE2814710A1 (en) 1978-10-12
US4129727A (en) 1978-12-12
US4137403A (en) 1979-01-30
US4129725A (en) 1978-12-12
NL7803434A (en) 1978-10-13
BE865882A (en) 1978-10-11
GB1568018A (en) 1980-05-21
FR2387217B2 (en) 1981-04-30
CH635072A5 (en) 1983-03-15
US4129726A (en) 1978-12-12
US4130720A (en) 1978-12-19
US4127569A (en) 1978-11-28

Similar Documents

Publication Publication Date Title
US4129724A (en) 9-Deoxy-9-methylene-PGF-3,4-didehydropiperidylamides
US4119672A (en) Inter-oxa-9-deoxy-9,10-didehydro-PGD1 compounds
US4089878A (en) ω-ARYL-9-DEOXY-PGF compounds
US4119649A (en) ω-Aryl-9-deoxy-9-methylene-PGF-type compounds
US4145561A (en) 2-Decarboxy-2-hydroxymethyl-9-deoxy-9-methylene-16-phenyl-PGF compounds
US4145365A (en) 2-decarboxy-2-alkylcarbonyl-9-deoxy-9,10-didehydro-pgd compounds
US4163842A (en) 5-Hydroxy-PGI1 piperidylamides
US4166187A (en) 9-deoxy-9-methylene-16-phenyl-5,6-didehydro-pgf2 or 4,4,5,5-tetradehydro-pgf1 compounds
US4191707A (en) 2-Decarboxy-2-aminomethyl-9-deoxy-9-methylene-16-phenyl-PGF compounds
US4171327A (en) 2-Decarboxy-2-alkylcarbonyl-PGF compounds
US4166903A (en) 5-Hydroxy-PGI1 pyrrolidylamides
US4167624A (en) 5-Hydroxy-PGI1 pyrrolinylamides
US4170703A (en) 5-Hydroxy-PGI1 morpholinylamides
US4230629A (en) 16-Phenoxy-9-deoxy-9-methylene-PGF compounds
US4226984A (en) 2-Decarboxy-2-aminomethyl-trans-4,5-didehydro-PGI1 compounds
US4164501A (en) 2-Decarboxy-2-hydroxymethyl-trans-4,5,13,14-tetradehydro-PGI1 compounds
US4119650A (en) Thromboxane B dialkyl-acetal diol intermediates
US4192948A (en) Trans-2,3-didehydro-9-deoxy-9-methylene-ω-aryl-PGF compounds
US4160102A (en) ω-Aryl-inter-oxa-9-deoxy-PGD1 compounds
US4206146A (en) 2-Decarboxy-2-aminomethyl-trans-2,3-didehydro-9-deoxy-9-methylene-PGF compounds
US4164502A (en) 2-Decarboxy-2-aminomethyl-trans-4,5,13,14-tetradehydro-PGI1 compounds
US4188332A (en) Trans-2,3-didehydro-9-deoxy-9-methylene-PGF,1,11- or 1,15-lactones